Dalton Pharma Services, a North American pharmaceutical cGMP contract manufacturing company, has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm committed to the clinical development of novel and affordable drugs to address unmet medical needs in autoimmunity, inflammation and infectious diseases. Under the signed agreement,…